drugset / Trial / NCT00547599

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

NCT00547599

Phase 4 Completed 659 enrolled Eli Lilly and Company ICOS Corporation · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

To determine if patients who are distressed over having problems getting or maintaining an erection react differently to the medication than those who are not stressed over the issue.

Timeline

Start
2003-04
Primary completion
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 20 mg Oral

Indications